Neonatal mortality and outcome at the end of the first year of life in early onset urea cycle disorders—review and meta-analysis of observational studies published over more than 35 years
详细信息 查看全文
- 作者：Peter Burgard ; Stefan Kölker ; Gisela Haege…
- 刊名：Journal of Inherited Metabolic Disease
- 出版年：2016
- 出版时间：March 2016
- 年：2016
- 卷：39
- 期：2
- 页码：219-229
- 全文大小：1,590 KB
- 参考文献：Ah Mew N, Lanpher BC, Gropman A et al (2014) Urea cycle disorders overview. In: Pagon RA, Adam MP, Ardinger HH et al (eds) GeneReviews(R). Seattle (WA). http://www.ncbi.nlm.nih.gov/pubmed/20301396 24.8.2015
American College of Medical Genetics Newborn Screening Expert G (2006) Newborn screening: toward a uniform screening panel and system—executive summary. Pediatrics 117:S296–S307. doi:10.1542/peds.2005-2633I
Bachmann C (2003) Outcome and survival of 88 patients with urea cycle disorders: a retrospective evaluation. Eur J Pediatr 162:410–416. doi:10.1007/s00431-003-1188-9 CrossRef PubMed
Barendregt JJ, Doi SA (2011) MetaXL user guide version 2.2. EpiGear International Pty Ltd, Wilston, Australia
Barendregt JJ, Doi SA, Lee YY, Norman RE, Vos T (2013) Meta-analysis of prevalence. J Epidemiol Community Health 67:974–978. doi:10.1136/jech-2013-203104 CrossRef PubMed
Batshaw ML, Tuchman M, Summar M, Seminara J, Members of the Urea Cycle Disorders C (2014) A longitudinal study of urea cycle disorders. Mol Genet Metab 113:127–130. doi:10.1016/j.ymgme.2014.08.001 PubMedCentral CrossRef PubMed
Berlin JA, Golub RM (2014) Meta-analysis as evidence: building a better pyramid. JAMA 312:603–605. doi:10.1001/jama.2014.8167 CrossRef PubMed
Brusilow S, Horwich AL (2011) Urea cycle enzymes. In: Valle D (ed) The Online Metabolic and Molecular Bases of Inherited Disease. http://ommbid.mhmedical.com/content.aspx?bookid=971§ionid=62674945
Dhawan A, Puppi J, Hughes RD, Mitry RR (2010) Human hepatocyte transplantation: current experience and future challenges. Nat Rev Gastroenterol Hepatol 7:288–298. doi:10.1038/nrgastro.2010.44 CrossRef PubMed
E-IMDEuropean registry and network for Intoxication type Metabolic Diseaseshttps://www.eimd-registry.org/17.02.2015
Enns GM (2008) Neurologic damage and neurocognitive dysfunction in urea cycle disorders. Semin Pediatr Neurol 15:132–139. doi:10.1016/j.spen.2008.05.007 CrossRef PubMed
Enns GM, Berry SA, Berry GT, Rhead WJ, Brusilow SW, Hamosh A (2007) Survival after treatment with phenylacetate and benzoate for urea-cycle disorders. N Engl J Med 356:2282–2292. doi:10.1056/NEJMoa066596 CrossRef PubMed
Häberle J, Boddaert N, Burlina A et al (2012) Suggested guidelines for the diagnosis and management of urea cycle disorders. Orphanet J Rare Dis 7:32. doi:10.1186/1750-1172-7-32 PubMedCentral CrossRef PubMed
Hedges LV (1989) An unbiased correction for sampling error in validity generalization studies. J Appl Psychol 74:469CrossRef
Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558. doi:10.1002/sim.1186 CrossRef PubMed
Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560. doi:10.1136/bmj.327.7414.557 PubMedCentral CrossRef PubMed
Jackson D, White IR, Riley RD (2012) Quantifying the impact of between-study heterogeneity in multivariate meta-analyses. Stat Med 31:3805–3820. doi:10.1002/sim.5453 PubMedCentral CrossRef PubMed
Keskinen P, Siitonen A, Salo M (2008) Hereditary urea cycle diseases in Finland. Acta Paediatr 97:1412–1419. doi:10.1111/j.1651-2227.2008.00923.x CrossRef PubMed
Kido J, Nakamura K, Mitsubuchi H et al (2012) Long-term outcome and intervention of urea cycle disorders in Japan. J Inherit Metab Dis 35:777–785. doi:10.1007/s10545-011-9427-0 CrossRef PubMed
Knapp G, Hartung J (2003) Improved tests for a random effects meta-regression with a single covariate. Stat Med 22:2693–2710. doi:10.1002/sim.1482 CrossRef PubMed
Kölker S, Cazorla AG, Valayannopoulos V et al (2015a) The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 1: the initial presentation. J Inherit Metab Dis. doi:10.1007/s10545-015-9839-3
Kölker S, Dobbelaere D, Haberle J et al (2015b) Networking across borders for individuals with organic acidurias and urea cycle disorders: The E-IMD consortium. JIMD Rep 22:29–38. doi:10.1007/8904_2015_408
Kölker S, Valayannopoulos V, Burlina AB et al (2015c) The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 2: the evolving clinical phenotype. J Inherit Metab Dis. doi:10.1007/s10545-015-9840-x
Lewis S, Clarke M (2001) Forest plots: trying to see the wood and the trees. BMJ 322:1479–1480PubMedCentral CrossRef PubMed
Lichter-Konecki U, Nadkarni V, Moudgil A et al (2013) Feasibility of adjunct therapeutic hypothermia treatment for hyperammonemia and encephalopathy due to urea cycle disorders and organic acidemias. Mol Genet Metab 109:354–359. doi:10.1016/j.ymgme.2013.05.014 CrossRef
Maestri NE, Hauser ER, Bartholomew D, Brusilow SW (1991) Prospective treatment of urea cycle disorders. J Pediatr 119:923–928CrossRef PubMed
McBride KL, Miller G, Carter S, Karpen S, Goss J, Lee B (2004) Developmental outcomes with early orthotopic liver transplantation for infants with neonatal-onset urea cycle defects and a female patient with late-onset ornithine transcarbamylase deficiency. Pediatrics 114:e523–e526. doi:10.1542/peds.2004-0198 CrossRef
Meyburg J, Hoffmann GF (2010) Liver, liver cell and stem cell transplantation for the treatment of urea cycle defects. Mol Genet Metab 100(Suppl 1):S77–S83. doi:10.1016/j.ymgme.2010.01.011 CrossRef PubMed
Morioka D, Kasahara M, Takada Y et al (2005) Current role of liver transplantation for the treatment of urea cycle disorders: a review of the worldwide English literature and 13 cases at Kyoto University. Liver Transpl 11:1332–1342. doi:10.1002/lt.20587 CrossRef PubMed
Nagata N, Matsuda I, Oyanagi K (1991) Estimated frequency of urea cycle enzymopathies in Japan. Am J Med Genet 39:228–229. doi:10.1002/ajmg.1320390226 CrossRef PubMed
Nassogne MC, Heron B, Touati G, Rabier D, Saudubray JM (2005) Urea cycle defects: management and outcome. J Inherit Metab Dis 28:407–414. doi:10.1007/s10545-005-0303-7 CrossRef PubMed
Nettesheim S, Häberle J, Karall D et al (2013) Neu diagnostizierte Harnstoffzyklusdefekte bei Patienten unter 16 Jahren. Monatsschr Kinderheilkd 161(Suppl 2):166
Nyhan WL, Barshop BA, Al-Aqeel AI (2012) Atlas of inherited metabolic diseases. Hodder Arnold, London
Rowe PC, Newman SL, Brusilow SW (1986) Natural history of symptomatic partial ornithine transcarbamylase deficiency. N Engl J Med 314:541–547. doi:10.1056/NEJM198602273140903 CrossRef PubMed
Rücker G, Schwarzer G, Carpenter JR, Schumacher M (2008) Undue reliance on I(2) in assessing heterogeneity may mislead. BMC Med Res Methodol 8:79. doi:10.1186/1471-2288-8-79 PubMedCentral CrossRef PubMed
Seminara J, Tuchman M, Krivitzky L et al (2010) Establishing a consortium for the study of rare diseases: The Urea Cycle Disorders Consortium. Mol Genet Metab 100(Suppl 1):S97–S105. doi:10.1016/j.ymgme.2010.01.014 PubMedCentral CrossRef PubMed
Statistical Package R (2009) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna
Summar ML, Koelker S, Freedenberg D et al (2013) The incidence of urea cycle disorders. Mol Genet Metab 110:179–180. doi:10.1016/j.ymgme.2013.07.008 PubMedCentral CrossRef PubMed
Urea Cycle Disorders Consortium (UCDC) of the Rare Diseases Clinical Research Networkhttps://www.rarediseasesnetwork.org/ucdc/17.02.2015
Uchino T, Endo F, Matsuda I (1998) Neurodevelopmental outcome of long-term therapy of urea cycle disorders in Japan. J Inherit Metab Dis 21(Suppl 1):151–159CrossRef
Urea Cycle Disorders Conference (2001) Consensus statement from a conference for the management of patients with urea cycle disorders. J Pediatr 138:S1–S5CrossRef
Viechtbauer W (2010) Conducting meta-analyses in R with the metafor package. J Stat Softw 36:1–48CrossRef
Walker V (2014) Ammonia metabolism and hyperammonemic disorders. Adv Clin Chem 67:73–150. doi:10.1016/bs.acc.2014.09.002 CrossRef PubMed
Wijburg FA, Nassogne MC (2012) Disorders of the urea cycle and related enzymes. In: Saudubray JM, van den Berghe G, Walter JH (eds) Inborn metabolic diseases. Springer, Berlin, pp 297–310CrossRef
Wilcken B (2004) Problems in the management of urea cycle disorders. Mol Genet Metab 81(Suppl 1):S86–S91. doi:10.1016/j.ymgme.2003.10.016 CrossRef PubMed
Wraith JE (2001) Ornithine carbamoyltransferase deficiency. Arch Dis Child 84:84–88PubMedCentral CrossRef PubMed - 作者单位：Peter Burgard (1)
Stefan Kölker (1)
Gisela Haege (1)
Martin Lindner (2)
Georg F. Hoffmann (1)
1. Centre for Paediatric and Adolescent Medicine, Division for Neuropaediatrics and Metabolic Medicine, Heidelberg University Hospital, Im Neuenheimer Feld 430, D-69120, Heidelberg, Germany
2. University Hospital Frankfurt, Children’s Hospital, Theodor-Stern-Kai 7, D-60590, Frankfurt am Main, Germany - 刊物类别：Medicine
- 刊物主题：Medicine & Public Health
Internal Medicine
Metabolic Diseases
Human Genetics
Biochemistry
Pediatrics - 出版者：Springer Netherlands
- ISSN：1573-2665
文摘
Background For urea cycle disorders (UCD), proportions and mortality of early onset (EO) patients, as well as outcome at one year of life show large variability. We aimed to integrate available evidence to create benchmarks for new diagnostic and therapeutic strategies.